Stocks TelegraphStocks Telegraph
Stock Ideas

PTN Company Profile and Key Details

NASDAQ : PTN

Palatin Technologies

$9.52
-0.48-4.80%
At Close 4:00 PM
67.49
BESG ScoreESG Rating

Price Chart

Stock Price Today

Palatin Technologies, Inc. (PTN) stock declined over -4.80%, trading at $9.52 on NASDAQ, down from the previous close of $10.00. The stock opened at $9.88, fluctuating between $9.50 and $10.04 in the recent session.

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 13, 20269.8910.199.509.528.55K
Jul 10, 202610.2910.299.7710.0014.55K
Jul 09, 20269.9810.969.9810.497.87K
Jul 08, 202610.5510.6810.2210.2717.77K
Jul 07, 202611.4011.409.7810.9915.79K
Jul 06, 202611.5111.6010.7311.0112.07K
Jul 02, 202610.8811.7110.1111.5925.55K
Jul 01, 202611.2211.229.7510.33147.05K
Jun 30, 202610.4611.3510.2310.7914.27K
Jun 29, 202611.0111.0110.0510.3436.7K
Jun 26, 202610.8611.5610.8611.4428.85K
Jun 25, 202610.9010.9010.2510.2511.58K
Jun 24, 202611.0111.019.9910.6023.8K
Jun 23, 202611.3012.1811.0011.2116.25K
Jun 22, 202611.3111.9511.3111.7723.42K
Jun 18, 202611.9112.2111.7211.7211K
Jun 17, 202612.2512.2512.2412.253.07K
Jun 16, 202612.5112.5111.3111.8715.97K
Jun 15, 202614.0114.0112.0512.5021.7K
Jun 12, 202613.7014.4113.0013.606.86K

Contact Details

Monmouth Junction, NJ 08512

United States

https://palatin.com609 495 2200

About Company

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Company Information

Employees29
Beta-0.11
Sales or Revenue$0.00
5Y Sales Change%-1%
Fiscal Year EndsJune
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Palatin Technologies, Inc. (PTN) stock price?
Palatin Technologies, Inc. (NASDAQ: PTN) stock price is $9.52 in the last trading session. During the trading session, PTN stock reached the peak price of $10.04 while $9.50 was the lowest point it dropped to. The percentage change in PTN stock occurred in the recent session was -4.8% while the dollar amount for the price change in PTN stock was - $0.48.
PTN's industry and sector of operation?
The NASDAQ listed PTN is part of Biotechnology industry that operates in the broader Healthcare sector. Palatin Technologies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of PTN?
Burns McClellan
Vice President of Investor Relations
Dr. Carl Spana Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Michael B. Raizman M.D.
Chief Medical Officer
Mr. Robert Jordan
Senior Vice President of Program Operations
Mr. James E. Hattersley
Senior Vice President of Bus. Devel.
Mr. John Dodd Ph.D.
Senior Vice President of Preclinical Devel.
Mr. Stephen A. Slusher Esq.
Chief Legal Officer
How PTN did perform over past 52-week?
PTN's closing price is 90.4% higher than its 52-week low of $5.00 where as its distance from 52-week high of $31.00 is -69.29%.
How many employees does PTN have?
Number of PTN employees currently stands at 29.
Link for PTN official website?
Official Website of PTN is: https://palatin.com
How do I contact PTN?
PTN could be contacted at phone 609 495 2200 and can also be accessed through its website. PTN operates from 11 Deer Park Drive, Monmouth Junction, NJ 08512, United States.
How many shares of PTN are traded daily?
PTN stock volume for the day was 8.5K shares. The average number of PTN shares traded daily for last 3 months was 17.33K.
What is the market cap of PTN currently?
The market value of PTN currently stands at $247.58M with its latest stock price at $9.52 and 1.78M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph